Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.36B
EV5.36B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
64.7
65.9
70.6
79.0
82.4
74.2
95.4
—
Revenue % Chg.
—
1.8%
7.2%
11.9%
4.3%
-9.9%
28.5%
—
Cost of Revenue
10.0
9.8
9.3
9.3
9.2
9.0
11.1
—
Gross Profit
54.7
56.1
61.3
69.7
73.3
65.2
84.3
—
Gross Profit Margin
84.6%
85.1%
86.8%
88.2%
88.9%
87.8%
88.4%
—
R&D Expenses
2.4
2.5
2.9
4.5
4.9
4.3
8.0
—
Selling, General, & Admin Expenses
34.4
34.9
37.4
41.4
43.5
39.4
47.4
—
Other Expenses
5.6
5.1
4.8
4.8
5.4
5.5
5.6
—
Operating Income
12.3
13.6
16.2
18.9
21.9
19.5
25.7
—
Operating Income Margin
18.9%
20.6%
23.0%
24.0%
26.6%
26.2%
26.9%
—
Total Other Income/Expenses Net
1.0
-0.1
0.3
-0.0
-0.3
-0.2
-0.3
—
Income Before Tax
13.3
13.5
16.5
18.9
21.6
19.3
25.4
—
Income Before Tax Margin
20.5%
20.4%
23.4%
23.9%
26.2%
26.0%
26.7%
—
Income Tax Expense
1.9
2.2
2.4
2.5
2.7
2.7
3.0
—
Net Income
11.2
11.3
14.1
16.4
18.9
16.7
22.5
—
Net Income Margin
17.3%
17.1%
19.9%
20.8%
22.9%
22.5%
23.6%
—
Weighted Avg. Shares Out
139.9
141.0
140.0
139.4
168.5
188.4
186.3
—
EPS
0.1
0.1
0.1
0.1
0.1
0.1
0.1
—
EPS % Chg.
—
—
25.5%
17.4%
-4.9%
-20.8%
36.1%
—
Weighted Avg. Shares Out Dil
139.9
141.0
140.0
139.4
168.5
188.4
186.3
—
EPS Diluted
0.1
0.1
0.1
0.1
0.1
0.1
0.1
—
Interest Income
0.1
0.1
0.1
0.1
0.2
0.6
1.8
—
Interest Expense
0.3
0.1
-0.1
-0.1
-0.2
0.6
0.1
—
EBIT
13.1
13.5
16.7
19.0
22.1
19.3
27.1
—
EBIT Margin
20.3%
20.5%
23.6%
24.1%
26.8%
26.0%
28.4%
—
Depreciation & Amortization
1.7
1.8
1.8
2.1
0.0
-1.8
1.7
—
EBITDA
14.8
15.3
18.5
21.2
22.1
17.6
28.9
—
EBITDA Margin
22.9%
23.3%
26.2%
26.8%
26.8%
23.7%
30.3%
—